Abstract
Endothelium plays a crucial role in modulating vascular function and structure, mainly by production of nitric oxide which protects the vasculature against the development of atherosclerosis and thrombosis. Traditional cardiovascular risk factors are characterized by endothelial dysfunction caused by an enhanced production of oxidative stress leading to destroy NO thus reducing its availability. A reduced endothelium-dependent relaxation is a predictor of cardiovascular events in high risk patients.
Abdominal obesity is associated with microvascular endothelial dysfunction, through indirect mechanisms, such as insulin-resistance and the association with risk factors (including diabetes mellitus, hypertension and dyslipidemia), and directly, among others, by the production of adipokines and pro-inflammatory cytokines which in turn induce oxidative stress leading to a reduced NO availability. Several systems are amplified by the concomitant obesity and hypertension, thus generating a perpetual vicious circle which further contribute to the pathogenesis/progression of microvascular disease.
Weight loss and modification of life-style ameliorate endothelial function in obese patients. It is conceivable that endothelial dysfunction might represent a complementary but crucial objective of a modern therapeutical approach leading to improve the prognosis in many patients, including obese patients, exposed to a high cardiovascular risk.
Keywords: Endothelium, obesity, nitric oxide, adipokines, inflammation, vascular function, diabetes mellitus, hypertension, dyslipidemia, cardiovascular risk
Current Pharmaceutical Design
Title:Microvascular Endothelial Dysfunction in Obesity and Hypertension
Volume: 19 Issue: 13
Author(s): Agostino Virdis, Mario Fritsch Neves, Emiliano Duranti, Giampaolo Bernini and Stefano Taddei
Affiliation:
Keywords: Endothelium, obesity, nitric oxide, adipokines, inflammation, vascular function, diabetes mellitus, hypertension, dyslipidemia, cardiovascular risk
Abstract: Endothelium plays a crucial role in modulating vascular function and structure, mainly by production of nitric oxide which protects the vasculature against the development of atherosclerosis and thrombosis. Traditional cardiovascular risk factors are characterized by endothelial dysfunction caused by an enhanced production of oxidative stress leading to destroy NO thus reducing its availability. A reduced endothelium-dependent relaxation is a predictor of cardiovascular events in high risk patients.
Abdominal obesity is associated with microvascular endothelial dysfunction, through indirect mechanisms, such as insulin-resistance and the association with risk factors (including diabetes mellitus, hypertension and dyslipidemia), and directly, among others, by the production of adipokines and pro-inflammatory cytokines which in turn induce oxidative stress leading to a reduced NO availability. Several systems are amplified by the concomitant obesity and hypertension, thus generating a perpetual vicious circle which further contribute to the pathogenesis/progression of microvascular disease.
Weight loss and modification of life-style ameliorate endothelial function in obese patients. It is conceivable that endothelial dysfunction might represent a complementary but crucial objective of a modern therapeutical approach leading to improve the prognosis in many patients, including obese patients, exposed to a high cardiovascular risk.
Export Options
About this article
Cite this article as:
Virdis Agostino, Fritsch Neves Mario, Duranti Emiliano, Bernini Giampaolo and Taddei Stefano, Microvascular Endothelial Dysfunction in Obesity and Hypertension, Current Pharmaceutical Design 2013; 19 (13) . https://dx.doi.org/10.2174/1381612811319130006
DOI https://dx.doi.org/10.2174/1381612811319130006 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
Call for Papers in Thematic Issues
"Tuberculosis Prevention, Diagnosis and Drug Discovery"
The Nobel Prize-winning discoveries of Mycobacterium tuberculosis and streptomycin have enabled an appropriate diagnosis and an effective treatment of tuberculosis (TB). Since then, many newer diagnosis methods and drugs have been saving millions of lives. Despite advances in the past, TB is still a leading cause of infectious disease mortality ...read more
Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions
Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more
Emerging and re-emerging diseases
Faced with a possible endemic situation of COVID-19, the world has experienced two important phenomena, the emergence of new infectious diseases and/or the resurgence of previously eradicated infectious diseases. Furthermore, the geographic distribution of such diseases has also undergone changes. This context, in turn, may have a strong relationship with ...read more
Melanoma and Non-Melanoma Skin Cancer Treatment: Standard of Care and Recent Advances
In this thematic issue, we aim to provide a standard of care of the diagnosis and treatment of melanoma and non-melanoma skin cancer. The editor will invite authors from different countries who will write review articles of melanoma and non-melanoma skin cancers. The Diagnosis, Staging, Surgical Treatment, Non-Surgical Treatment all ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Forward and Backward Aortic Components and Reflection Indexes in Children and Adolescents: Determinants and Role in High Pressure States
Current Hypertension Reviews Aquaretic Agents: Whats Beyond the Treatment of Hyponatremia?
Current Pharmaceutical Design Novel Neuropeptides as Ligands of Orphan G Protein-Coupled Receptors
Current Pharmaceutical Design Obstetrical Hemorrhage Review
Current Women`s Health Reviews Pharmacogenomic Considerations in the Treatment of the Pediatric Cardiomyopathy Called Barth Syndrome
Recent Patents on Biotechnology Anti-hyperglycemic Properties of a Purified Proteinaceous Protease Inhibitor from Macrotyloma Uniflorum Seeds
Current Topics in Medicinal Chemistry Clinical Significance of the New Cardiovascular Risk Markers in Diabetes Mellitus
Current Diabetes Reviews Antioxidant Therapy in Diabetic Complications: What is New?
Current Vascular Pharmacology β3-Adrenoceptor Control of Lower Genitourinary Tract Organs and Function in Male: An Overview
Current Drug Targets Cardiovascular Effects of Liraglutide
Current Hypertension Reviews The Effect of Anti-B-cell Therapy on the Development of Atherosclerosis in Patients with Rheumatoid Arthritis
Current Pharmaceutical Design Soluble Amyloid-β Levels and Late-Life Depression
Current Pharmaceutical Design Cardiovascular Disease and Diabetes in South Asians: The Twin Epidemic
Current Diabetes Reviews The Prostaglandin Agonist Beraprost Aggravates Doxorubicin-mediated Apoptosis by Increasing iNOS Expression in Cardiomyocytes
Current Vascular Pharmacology The Heme Oxygenase/Biliverdin Reductase Pathway in Drug Research and Development
Current Drug Metabolism Androgen Deficiency in Aging Male Questionnaire for the Clinical Detection of Testosterone Deficiency in a Population of Black Sub-Saharan African Men with Type 2 Diabetes Mellitus: Is it a Reliable Tool?
Current Diabetes Reviews Hypersensitivity Reactions to Ophthalmic Products
Current Pharmaceutical Design Hemodynamic Changes of Hepatic & Renal Vessels in Systemic Bacterial Infection with Fever in HCV Related Cirrhosis
Infectious Disorders - Drug Targets Variability in Response to Cardiovascular Drugs
Current Clinical Pharmacology Life and Death Partners in Post-PCI Restenosis: Apoptosis, Autophagy, and The Cross-talk Between Them
Current Drug Targets